Procter & Gamble Company (The) $PG Stock Sold by Narwhal Capital Management

Narwhal Capital Management lowered its position in Procter & Gamble Company (The) (NYSE:PG) by 17.4% during the 3rd quarter, HoldingsChannel reports. The firm owned 71,114 shares of the company’s stock after selling 14,963 shares during the period. Narwhal Capital Management’s holdings in Procter & Gamble were worth $10,331,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in PG. Cassia Capital Partners LLC boosted its position in shares of Procter & Gamble by 3.2% during the 3rd quarter. Cassia Capital Partners LLC now owns 8,515 shares of the company’s stock valued at $1,237,000 after acquiring an additional 263 shares during the last quarter. DMKC Advisory Services LLC increased its position in shares of Procter & Gamble by 4.9% in the third quarter. DMKC Advisory Services LLC now owns 23,837 shares of the company’s stock worth $3,463,000 after purchasing an additional 1,109 shares during the last quarter. Torrey Growth & Income Advisors raised its stake in Procter & Gamble by 2.2% in the third quarter. Torrey Growth & Income Advisors now owns 4,725 shares of the company’s stock valued at $700,000 after purchasing an additional 100 shares in the last quarter. Global Wealth Management Investment Advisory Inc. raised its stake in Procter & Gamble by 3.6% in the third quarter. Global Wealth Management Investment Advisory Inc. now owns 47,642 shares of the company’s stock valued at $6,921,000 after purchasing an additional 1,648 shares in the last quarter. Finally, 71 West Capital Partners raised its stake in Procter & Gamble by 1.0% in the third quarter. 71 West Capital Partners now owns 15,914 shares of the company’s stock valued at $2,312,000 after purchasing an additional 161 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: PG’s Beauty business posted 5% organic sales growth in fiscal Q1 2027, supported by Pantene and SK-II, product innovation, and stronger brand execution. Sustaining that momentum could help support growth, though its impact on the broader business remains uncertain. Article: Is Procter & Gamble’s Beauty Momentum Enough to Lift Growth?
• Neutral Sentiment: P&G named Shalini Saraswat Brand Director and Business Head for Pantene India, bringing prior P&G brand leadership and R&D experience. The appointment supports the company’s focus on hair care in India, but no expected financial effect was specified. Article: What Does Procter & Gamble Naming a New India Beauty Head Signal?
• Neutral Sentiment: In an advertising challenge brought by P&G, the National Advertising Division concluded that Unilever had substantiation for its challenged Dove body-wash moisturizing claims. This is a competitive setback for P&G, but no direct financial impact was reported. Article: National Advertising Division Found Unilever’s Dove Deep Moisture Body Wash Claims Supported
• Negative Sentiment: CEO Juliana Mont Santos sold 5,370 shares and CFO Andre Schulten sold 30,677 shares, both at $169 on Nov. 5. Each retained shares, but the sales and reductions in their respective holdings could weigh on investor sentiment. Article: Procter & Gamble CFO Andre Schulten Sells Shares CEO SEC filing

Insider Transactions at Procter & Gamble

In other news, insider Victor Aguilar sold 18,812 shares of the company’s stock in a transaction on Friday, October 30th. The shares were sold at an average price of $164.43, for a total value of $3,093,257.16. Following the completion of the sale, the insider owned 55,243 shares of the company’s stock, valued at approximately $9,083,606.49. This represents a 25.40% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Juliana Azevedo sold 5,370 shares of the stock in a transaction on Thursday, November 5th. The shares were sold at an average price of $169.00, for a total transaction of $907,530.00. Following the transaction, the chief executive officer directly owned 21,361 shares in the company, valued at approximately $3,610,009. This represents a 20.09% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 197,756 shares of company stock worth $32,336,001. Corporate insiders own 0.23% of the company’s stock.

Analyst Upgrades and Downgrades

PG has been the subject of several research analyst reports. UBS Group set a $166.00 target price on shares of Procter & Gamble in a research report on Friday, October 23rd. JPMorgan Chase & Co. increased their price target on shares of Procter & Gamble from $162.00 to $180.00 and gave the stock an “overweight” rating in a report on Friday, October 23rd. TD Cowen raised their price objective on shares of Procter & Gamble from $150.00 to $166.00 and gave the company a “hold” rating in a research report on Friday, October 23rd. Morgan Stanley lifted their price objective on shares of Procter & Gamble from $166.00 to $185.00 and gave the stock an “overweight” rating in a report on Friday, October 23rd. Finally, Piper Sandler upped their target price on shares of Procter & Gamble from $145.00 to $167.00 and gave the stock a “neutral” rating in a research report on Monday, October 26th. Fifteen investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus price target of $170.57.

Procter & Gamble Stock Performance

Shares of NYSE PG opened at $168.43 on Wednesday. The stock’s 50-day moving average is $152.95 and its 200 day moving average is $149.64. The stock has a market cap of $390.38 billion, a price-to-earnings ratio of 25.37, a P/E/G ratio of 4.14 and a beta of 0.36. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $170.52. The company has a current ratio of 0.72, a quick ratio of 0.53 and a debt-to-equity ratio of 0.40.

Procter & Gamble (NYSE:PG) last issued its earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The business had revenue of $23.28 billion during the quarter, compared to analyst estimates of $22.80 billion. During the same quarter in the prior year, the firm earned $1.99 earnings per share. Procter & Gamble’s revenue for the quarter was up 4.0% on a year-over-year basis. On average, sell-side analysts anticipate that Procter & Gamble Company will post 6.99 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be issued a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date is Friday, October 23rd. Procter & Gamble’s payout ratio is presently 65.51%.

Procter & Gamble Company Profile

The Procter & Gamble Company is a consumer goods company that develops, manufactures and markets products for everyday use. Founded in 1837 by William Procter and James Gamble, the company is headquartered in Cincinnati, Ohio. Its products span beauty, grooming, health care, fabric and home care, and baby, feminine and family care. Well-known brands include Tide, Pampers, Gillette, Pantene, Olay, Oral-B, Crest, Dawn, Charmin and Bounty. Procter & Gamble sells its products in markets around the world through retail stores, e-commerce platforms and other distribution channels.